What does the evidence say about Moringa Blood Pressure Meta-Analysis?

The current Migaku evidence database contains 2 reusable source documents for Moringa Blood Pressure Meta-Analysis. This answer focuses on benefits, uncertainty, and practical interpretation. - Moringa oleifera is suggested as an antihypertensive and anti-obesity agent, but there is insufficient evidence to establish a causal link between Moringa oleifera and reductions in blood pressure and body measurements in humans. [Samarin MM (2026); evidence level 1] - The results indicated that Moringa oleifera consumption significantly reduced systolic blood pressure (SBP) by weighted mean differences (WMDs): -6.00 mmHg, p p p = 0.435) and body weight ( p = 0.938) compared to those who did not consume Moringa oleifera . [Samarin MM (2026); evidence level 1] - This systematic review and meta-analysis seek to examine the effects of Moringa oleifera on body weight and blood pressure. [Samarin MM (2026); evidence level 1] - According to the World Health Organization of 2025, the NCDs remain a global health burden that increases the risk of mortality []. [Mokgalaboni Kabelo (2026); evidence level 1] - Among widely available standard treatments is Glucophage, such as metformin, and its long-term use is associated with lactic acidosis, hypoglycemia, and vitamin Bdeficiency, and the latter promotes neuropathy [,,,]. [Mokgalaboni Kabelo (2026); evidence level 1] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.